BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36604205)

  • 1. Readiness to Provide Oral and Injectable PrEP for Sexual and Gender Minority Youth Among Healthcare Providers and Clinics in the U.S. Northeast.
    Valente PK; Rusley JC; Operario D; Biello KB
    J Adolesc Health; 2023 May; 72(5):722-729. PubMed ID: 36604205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual, Interpersonal, and Structural Factors That Influence Intentions to Use Pre-exposure Prophylaxis Among Sexual Minority Men in Miami.
    Rogers BG; Harkness A; Satyanarayana S; Pachankis J; Safren SA
    Arch Sex Behav; 2023 Feb; 52(2):741-750. PubMed ID: 35536492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland.
    Kaptchuk RP; Thomas AM; Dhir AM; Solomon SS; Clipman SJ
    BMC Public Health; 2024 May; 24(1):1258. PubMed ID: 38720248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Free Testing and PrEP without Outing Myself to Parents:" Motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men.
    Fisher CB; Fried AL; Ibrahim Puri L; Macapagal K; Mustanski B
    PLoS One; 2018; 13(7):e0200560. PubMed ID: 30044845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada.
    Grace D; Gaspar M; Wells A; Sinno J; Daroya E; Montess M; Hull M; Lachowsky NJ; Tan DHS
    AIDS Patient Care STDS; 2023 Jun; 37(6):306-315. PubMed ID: 37195728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider-Patient Communication on Pre-Exposure Prophylaxis (Prep) for HIV Prevention: An Exploration of Healthcare Provider Challenges.
    Wilson K; Bleasdale J; Przybyla SM
    Health Commun; 2021 Nov; 36(13):1677-1686. PubMed ID: 32633137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
    Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
    J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.
    Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Gaston Hawkins LA; Hansen NB; Kershaw TS; Underhill K; Betancourt JR; Dovidio JF
    PLoS One; 2016; 11(6):e0157324. PubMed ID: 27304883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
    John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
    Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding adaptive responses in PrEP service delivery in Belgian HIV clinics: a multiple case study using an implementation science framework.
    Vanhamel J; Reyniers T; Vuylsteke B; Callens S; Nöstlinger C; Huis In 't Veld D; Kenyon C; Van Praet J; Libois A; Vincent A; Demeester R; Henrard S; Messiaen P; Allard SD; Rotsaert A; Kielmann K
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26260. PubMed ID: 38965986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next Generation Pre-Exposure Prophylaxis for Young Men who have Sex with Men: Lessons from System and Provider-level barriers to oral PrEP.
    Valente PK; Bauermeister JA; Lin WY; Operario D; Rusley J; Hightow-Weidman L; Mayer KH; Biello KB
    AIDS Behav; 2022 Oct; 26(10):3422-3435. PubMed ID: 35445994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
    Roche SD; Barnabee G; Omollo V; Mogaka F; Odoyo J; Bukusi EA; Morton JF; Johnson R; Celum C; Baeten JM; O'Malley G
    BMC Health Serv Res; 2022 Mar; 22(1):422. PubMed ID: 35354456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance Between HIV Risk Perception, Sexual Behavior, and Pre-exposure Prophylaxis Adherence Among Young Sexual and Gender Minorities in the United States.
    Kelly NK; Rosso MT; Rainer C; Claude K; Muessig KE; Hightow-Weidman L
    J Adolesc Health; 2024 Jun; 74(6):1112-1117. PubMed ID: 38583158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.
    Mullins TL; Zimet G; Lally M; Kahn JA
    AIDS Patient Care STDS; 2016 Jul; 30(7):339-48. PubMed ID: 27410497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intimate Partner Violence and the Sexual Health of Sexual Minority Men.
    Storholm ED; Reynolds HE; Muthuramalingam S; Nacht CL; Felner JK; Wagner GJ; Stephenson R; Siconolfi DE
    LGBT Health; 2023 Sep; 10(S1):S39-S48. PubMed ID: 37754928
    [No Abstract]   [Full Text] [Related]  

  • 17. Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis Study.
    Valente PK; Bauermeister JA; Lin WY; Silva DTD; Hightow-Weidman L; Drab R; Mayer KH; Operario D; Rusley J; Biello KB
    AIDS Patient Care STDS; 2022 Nov; 36(11):431-442. PubMed ID: 36367995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tennessee Healthcare Provider Practices, Attitudes, and Knowledge Around HIV Pre-Exposure Prophylaxis.
    Moore E; Kelly SG; Alexander L; Luther P; Cooper R; Rebeiro PF; Zuckerman AD; Hargreaves M; Bourgi K; Schlundt D; Bonnet K; Pettit AC
    J Prim Care Community Health; 2020; 11():2150132720984416. PubMed ID: 33356793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.